Literature DB >> 18388036

Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.

Antonios Ziakas1, Stavros Gavrilidis, Efthimia Souliou, George Giannoglou, Ioannis Stiliadis, Haralambos Karvounis, George Efthimiadis, Sotirios Mochlas, M Arvanitidou Vayona, Apostolos Hatzitolios, Christos Savopoulos, Ifigenia Pidonia, George Parharidis.   

Abstract

BACKGROUND: We investigated the time course and prognostic value of fibrinogen (Fib), C-reactive protein (CRP), interleukin-6 (IL-6), and ceruloplasmin (CP) in patients with severe unstable angina.
METHODS: All 4 substances were measured on admission and after 6, 12, 24, 48, and 72 hours, and after 7 days and 6 months in 40 patients with Braunwald's classification class IIIB unstable angina.
RESULTS: All recorded substances increased significantly; 15 patients had cardiovascular events during hospitalization and 11 patients during follow-up. The time course and the mean values of Fib, CRP, and IL-6 were similar in patients with and without complications both during hospitalization and follow-up. However, CP levels from 6 hours until 6 months were significantly higher in patients with complications during follow-up (P < .05).
CONCLUSIONS: Fib, CRP, IL-6, and CP levels alter in patients with severe unstable angina. However, only CP levels were related to 12-month follow-up prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388036     DOI: 10.1177/0003319708314249

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases.

Authors:  Md Rukunuzzaman
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-06-29

2.  Ceruloplasmin as a prognostic marker in patients with bile duct cancer.

Authors:  In Woong Han; Jin-Young Jang; Wooil Kwon; Taesung Park; Yongkang Kim; Kyoung Bun Lee; Sun-Whe Kim
Journal:  Oncotarget       Date:  2017-04-25

Review 3.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

4.  Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort.

Authors:  Mehjar Azzouz; Yiyi Xu; Lars Barregard; Björn Fagerberg; Bengt Zöller; Peter Molnár; Anna Oudin; Mårten Spanne; Gunnar Engström; Leo Stockfelt
Journal:  Environ Health       Date:  2022-04-12       Impact factor: 5.984

5.  Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran.

Authors:  Seyyed Morteza Safavi; Rahele Ziaei; Mohammad Reza Maracy
Journal:  J Obes       Date:  2012-12-31

6.  Ceruloplasmin and the extent of heart failure in ischemic and nonischemic cardiomyopathy patients.

Authors:  Yifei Xu; Haiyan Lin; Ying Zhou; Gang Cheng; Geng Xu
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

Review 7.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.